You've seen them in your doctor's office: pens and notepads
labeled with the names of leading drugs or medical devices.
What you don't see are the free lunches, expense-paid trips
and lucrative consulting deals for physician lectures and
conferences.
Concerned that the goodies and other tactics by
drug or medical device companies can drive medical decisions,
the UC Davis Health System is considering strict limits on
meals and on payments for doctors to attend meetings or
participate in online medical education classes.
If UC Davis ultimately adopts the policies, it will join an
elite group of academic medical centers taking the same tack:
Stanford and Yale universities and the University of
Pennsylvania.
"We need to reaffirm the social contract under which we
practice medicine," said Dr. Garen Wintemute, an emergency
doctor and UC Davis professor who is leading the charge for
reforms. "Our primary responsibility is to the welfare of our
patients. Industry marketing practices interfere with our
ability to fulfill that responsibility"
The medical center's Pharmacy and Therapeutics Committee,
which oversees the purchase of drugs and devices for the
health system, voted last week to send three recommendations
to the medical center's executive committee for consideration:
• A ban on all gifts, free meals, payment for travel time
or time spent at meetings, and payment from drug or medical
device companies for participation in online medical education
programs.
• An end to the system that allows pharmaceutical sales
representatives to give doctors free drug samples for
patients. The former arrangement would be replaced with a
voucher system to benefit low-income patients.
• The exclusion of any medical professional with ties to
drug or device manufacturers from hospital and medical group
committees that oversee the purchase of drugs or medical
devices.
Four other recommendations aimed at eliminating potential
conflicts of interest are pending at the Pharmacy and
Therapeutics Committee level. The suggested changes come from
a proposal outlined for academic medical centers in a January
article in the Journal of the American Medical Association.
One such proposal would prohibit manufacturers from funding
medical education programs for health care providers. Instead,
companies could contribute to a central repository overseen by
the medical center for spending on education. Currently, about
90 percent of funding for physician education comes from
industry.
That was obvious last week during a conference on psychotic
disorders at the UC Davis MIND Institute. The conference was
supported by "educational grants" from four companies that
make anti-psychotic drugs. The drug makers had display tables
just outside the meeting room, where they handed out pamphlets
about their products, free pens and other goodies labeled with
their brand names.
In a statement last week, the Pharmaceutical Research and
Manufacturers of America (PhRMA) called efforts to restrict
such marketing efforts "a serious mistake."
"The general concern we have is that some of these very
restrictive policies are not necessary and may in fact cut
down on interactions between drug company reps and
physicians," said Scott Lassman, senior assistant general
counsel for PhRMA.
"This is not good for patients, because the reps have very
useful information about the medications."
Lassman added that PhRMA adopted its own code of ethics a
few years ago that asked industry members to end lavish
gift-giving.
Dr. Tim Albertson, chairman of Davis' Pharmacy and
Therapeutics Committee, said the proposals are the most recent
in a decadelong effort to re-evaluate drug company ties to the
university and to narrow relationships between doctors and the
drug and device industries.
Still, any proposed changes pose challenges to the health
system. He said drawing a line between marketing and
legitimate physician education can be difficult.
"What we are trying to do is bring light to the subject,"
he said. "We are not going to be police. But if we as an
institution make a statement, that has power."
If successful, UC Davis would be the second health system
in the Sacramento region to tighten its conflict of interest
policies. Two years ago, Kaiser Permanente adopted several
sweeping restrictions.
Those limits are working, said Dr. Sharon Levine, associate
executive director of Kaiser Permanente Northern California.
"It is protecting professionalism and ensuring our members
never have to worry about whose interests are being served
when a drug is prescribed or a hip implant is chosen for a
surgical procedure," said Levine.
UC Davis medical students have launched their own effort.
Second-year student Nelson Conley circulated a petition
calling for an end to industry freebies he said are used to
curry favor among students when they are most vulnerable to
influence.
Even as an undergraduate, Conley said he shadowed a
neurologist in private practice and enjoyed free Subway
sandwiches, deli platters and Chipotle burritos in exchange
for half-hour sessions with drug company reps.
"We will remember who helped us when we didn't have money
and we were hungry all the time," he said. "I think it's
inappropriate."
Conley has been asked to draft proposals for consideration
by the medical school's Committee on Educational Policy.
"I'm hoping it's the beginning of a tide shift," he said.
"It's a very slow process."
Conley and other proponents of policy changes say many
medical students and doctors don't believe they can be swayed
by the marketing tactics in question.
"They have almost always a universal view that none of this
has an influence on them because they are scientists and
accustomed to evaluating data objectively," said Jerome
Kassirer, former editor of the New England Journal of Medicine
and author of the book "On the Take: How Medicine's Complicity
with Big Business Can Endanger Your Health."
"That's a lot of baloney," he said.
Several studies in recent years have found that the rate of
drug prescriptions by doctors increases substantially after
they see sales representatives, attend company-supported
meetings or accept free samples, according to an article
published earlier this year in the Journal of the American
Medical Association.